Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
The Oncology Journal Club Episode 10
Today’s must-listen episode includes an in-depth review of two key papers, Quick Bites and an…
Radiation to treat paediatric cancers may have lasting impact on heart and metabolic health
Adult survivors of childhood abdominal and pelvic cancers who had been treated with radiation therapy…
Are differences in treatment driving variation in ovarian cancer survival internationally?
Ovarian cancer is an aggressive disease. In the UK, ovarian cancer is the 6th most…
ESMO 2016: Financial difficulties linked to worse outcomes from cancer treatment
Financial difficulties can significantly impact a cancer patient’s quality of life during treatment and may even increase their risk of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.